61703-339-18 · Carboplatin Injection · Hospira, Inc., a Pfizer Company
What is the package ndc for 61703-339-18 · Carboplatin Injection · Hospira, Inc., a Pfizer Company?
For 61703-339-18 · Carboplatin Injection · Hospira, Inc., a Pfizer Company, package ndc is 61703-339-18; generic name is Carboplatin Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Limited Availability, recorded from its source on 2026-09-01; source re-checked 2026-09-15.
"initial_posting_date": "04/28/2023", "package_ndc": "61703-339-18", "generic_name": "Carboplatin Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027"
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 61703-339-18 verified
- Generic name
- Carboplatin Injection verified
- Manufacturer
- Hospira, Inc., a Pfizer Company verified
- Status
- Current verified
- Availability now
- Limited Availability verified
- FDA note
- Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027 verified
- Initial posting date
- 04/28/2023 verified
- Last update date
- 08/24/2026 verified
- Days in shortage
- 1222 our reading
- Reason for shortage
- Demand increase for the drug verified
- Dosage form
- Injection verified
- Therapeutic category
- Oncology verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/24/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Demand increase for the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000